Fibrogen's obtuse anemia pill disclosures raise heart safety concern - STAT

Fibrogen's obtuse anemia pill disclosures raise heart safety concern - STAT

STAT Plus: Fibrogen’s obtuse disclosures about anemia pill raise concerns over heart safety, putting approval at risk

By ADAM FEUERSTEIN

The safety data remain obscured, so Fibrogen’s wobbly assurances about the heart safety of its anemia pill are raising more questions than were answered.

READ MORE